Indefinite Delivery Contract SPE2DB20D2200

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Numerous task orders have been placed against this IDC for the delivery of various pharmaceutical products, such as Nurtec ODT, Ozempic, Trulicity, Lidocaine patches, and other medications used to treat conditions like diabetes, cardiovascular health, pain management, and infectious diseases. The task orders, ranging from thousands to millions of dollars in ceiling value, do not have any set-aside designations, indicating open competition. All contract performance occurs at Amerisourcebergen's facility in Conshohocken, Pennsylvania. This IDC, along with a separate $750,000 IDC Amerisourcebergen holds with the Department of Justice Federal Bureau of Investigation, enables efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.